Real World TAVR Is All About Patient Selection

ACC Conference Reporter

AHA 2016 | NEW ORLEANS — In a real world registry trial comparing transcatheter aortic valve replacement (TAVR) to surgical aortic valve replacement (SAVR) in intermediate risk patients, the mortality at one year was nearly twice as high in the TAVR group, but those patients were also older and more frail than the surgery patients. Read More >>>

Keywords: AHA Annual Scientific Sessions, AHA16

< Back to Listings